News

Published on 31 Dec 2024 on Zacks · via Yahoo Finance

Corcept Submits Application for Another Cushing's Syndrome Drug


Article preview image

Corcept Therapeutics Incorporated CORT recently announced the submission of a new drug application...

NASDAQ.CORT price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Corcept Therapeutics Incorporated (CORT) Hit a 52 Week High, Can the Run...

Have you been paying attention to shares of Corcept Therapeutics (CORT)? Shares have been on the...

Zacks · via Yahoo Finance 24 Jan 2025

Here’s Why Analysts Are Bullish on Corcept Therapeutics Incorporated (CORT)

We recently compiled a list of the 12 Hot Stocks to Buy According to Analysts. In this article, w...

Insider Monkey · via Yahoo Finance 21 Jan 2025

Corcept Therapeutics Incorporated (CORT): Why Should You Buy This Growth Stock...

We recently compiled a list of the 15 Best Growth Stocks to Buy for the Next 5 Years. In this...

Insider Monkey · via Yahoo Finance 19 Jan 2025

Corcept Therapeutics Incorporated (CORT) Surged on Strong Results and Increased...

ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap...

Insider Monkey · via Yahoo Finance 7 Jan 2025

Corcept Submits Application for Another Cushing's Syndrome Drug

Corcept Therapeutics Incorporated CORT recently announced the submission of a new drug applicatio...

Zacks · via Yahoo Finance 31 Dec 2024

Will Corcept Therapeutics Incorporated (CORT) Make You Rich In 2025?

We recently compiled a list of the 10 Stocks That Will Make You Rich In 2025. In this article, we...

Insider Monkey · via Yahoo Finance 25 Dec 2024

CORT's Dazucorilant Fails to Meet Goal in Neurologic Disorder Study

Corcept Therapeutics Incorporated CORT announced data from the phase II DAZALS study evaluating i...

Zacks · via Yahoo Finance 12 Dec 2024

Beat the Market the Zacks Way: Oracle, American Healthcare, Palantir in Focus

Our time-tested methodologies were at work to help investors navigate the market well last week....

Zacks · via Yahoo Finance 25 Nov 2024

Corcept Shares Rise More Than 60% in Three Months: Here's Why

Shares of Corcept Therapeutics Incorporated CORT have rallied 60.7% in the past three months agai...

Zacks · via Yahoo Finance 22 Nov 2024

Corcept Therapeutics' Commercial Drug Korlym Sales Impress Despite Increased...

Corcept Therapeutics' Commercial Drug Korlym Sales Impress Despite Increased Competition, Analyst...

Benzinga · via Yahoo Finance 30 Sep 2024